Cardiovascular Risk and dyslipidemia Dr Stéphane De Wit St Pierre Hospital - Brussels.
Management of ARV 6th Advanced HIV Course, Montpellier, September 3-5, 2008 Jürgen Rockstroh, Department of Medicine I, University of Bonn, Germany.
00002-E-1 – 1 December 2003 Anti-HIV drugs 2010-2011 Andrea De Luca, M.D. Institute of Clinical Infectious Diseases. Catholic University, Rome 2nd Division.
CR EACS Cologne 11-14 Novembre 2009. LBPE9.7/8 - Prevalence of proximal renal tubular dysfunction (PRTD) and associated factors in HIV-infected patients,
Can we cure HIV/AIDS?: A 2014 progress report
Future HCV Treatment Paradigms Mark Sulkowski, MD Professor of Medicine Medical Director, Viral Hepatitis Center Divisions of Infectious Diseases and Gastroenterology
CR EACS Cologne
AMD management: what changes with a new player? Sobha Sivaprasad.
HIV-1 Resistance - Implications For Clinicians
Bone Turnover Suppression Based on an ASBMR/ECTS Clincal Debate “Too Much Suppression of Turnover Is Bad for Bone” Co-Chairs: Socrates Papapoulos, Douglas.
Supported by an unrestricted educational grant from
The Continuum of HIV Care -- US
